T2 Biosystems (TTOO) received an Intention to Grant a European Patent for EP Appl. No. 17205422.3, titled: METHODS FOR AMPLIFYING AND DETECTING PATHOGEN NUCLEIC ACID IN A WHOLE BLOOD SAMPLE - Patent E
Go back to T2 Biosystems (TTOO) received an Intention to Grant a European Patent for EP Appl. No. 17205422.3, titled: METHODS FOR AMPLIFYING AND DETECTING PATHOGEN NUCLEIC ACID IN A WHOLE BLOOD SAMPLE - Patent E(NASDAQ: TTOO) | Delayed: 2.99 +0.05 (1.70%) | |||||
---|---|---|---|---|---|---|
Previous Close | $2.94 | 52 Week High | $12.00 | |||
Open | $2.94 | 52 Week Low | $4.92 | |||
Day High | $3.00 | P/E | N/A | |||
Day Low | $2.88 | EPS | $0.00 | |||
Volume | 106,826 |